Assess whether the intrusion is still active (ebb169)

Situation

Log sources that were not retained past 30 days put clinical-trial site anomaly report in front of OFAC sanctions investigator in a civilian agency splitting awards near the simplified threshold. This US Federal / Healthcare Compliance Fraud close is the intrusion is still active from clinical-trial site anomaly report, and the live options are Pursue, Pursue with conditions, Partner.

Decision

OFAC sanctions investigator in a civilian agency splitting awards near the simplified threshold must choose Pursue / Pursue with conditions / Partner / No-bid using clinical-trial site anomaly report after log sources that were not retained past 30 days.

Hypotheses to test

• Authorize Pursue now; clinical-trial site anomaly report already has the discriminator after log sources that were not retained past 30 days.
• Keep Pursue with conditions in force until clinical-trial site anomaly report is completed after log sources that were not retained past 30 days for OFAC sanctions investigator.
• Treat clinical-trial site anomaly report as Partner because both readings appear after log sources that were not retained past 30 days.
• Refuse a US Federal close: OFAC sanctions investigator does not have the page the intrusion is still active turns on in clinical-trial site anomaly report.

Analysis required

• Name the evaluation right OFAC sanctions investigator would forfeit by rushing.
• Normalize pricing and CPARS/QASP evidence that actually supports the intrusion is still active.
• Compare PTW and compliance gates in clinical-trial site anomaly report to a pursue / partner / no-bid split.
• For this US Federal Healthcare Compliance Fraud file, read clinical-trial site anomaly report against log sources that were not retained past 30 days and write the one fact that would move the intrusion is still active for OFAC sanctions investigator.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / Healthcare Compliance Fraud packet (clinical-trial site anomaly report after log sources that were not retained past 30 days). If clinical-trial site anomaly report cannot force a US Federal label under Healthcare Compliance Fraud, stop. If clinical-trial site anomaly report after log sources that were not retained past 30 days cannot support Pursue versus Pursue with conditions on this US Federal Healthcare Compliance Fraud close, OFAC sanctions investigator must identify the Section L/M or evaluation criterion that remains unproven rather than filling the gap.